PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pneumology, COVID-19 Hospital \'M. Scarlato\', 84018 Scafati, Salerno, Italy.\', \'Istituto Zooprofilattico Sperimentale del Mezzogiorno, 80055 Portici, Naples, Italy.\', \'Unit of Virology and Microbiology, \'Umberto I\' Hospital, 84014 Nocera Inferiore, Salerno, Italy.\', \'Unit of Clinical Pathology Laboratory, COVID-19 Hospital \'M. Scarlato\', 84018 Scafati, Salerno, Italy.\', \'Department of Radiology, COVID-19 Hospital \'M. Scarlato\', 84018 Scafati, Salerno, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 65010.3390/v14030650
?:doi
?:hasPublicationType
?:journal
  • Viruses
is ?:pmid of
?:pmid
?:pmid
  • 35337057
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.805
?:rankingScore_hIndex
  • 52
?:title
  • Effects of Casirivimab/Imdevimab Monoclonal Antibody Treatment among Vaccinated Patients Infected by SARS-CoV-2 Delta Variant.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all